ווטריינט 400 מ"ג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

PAZOPANIB AS HYDROCHLORIDE 400 MG

Dostupno od:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC koda:

L01XE11

Farmaceutski oblik:

FILM COATED TABLETS

Administracija rute:

PER OS

Proizveden od:

GLAXO OPERATIONS UK LIMITED

Terapijska grupa:

PAZOPANIB

Terapijske indikacije:

Renal cell carcinoma (RCC)Votrient is indicated in adults for the first line treatment of advanced Renal Cell Carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease.Soft tissue sarcoma (STS)Votrient is indicated for the treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

Datum autorizacije:

2011-01-01